IOVANCE BIOTHERAPEUTICS, INC. 10-Q

Accession 0001558370-23-009134

Filing information

CIK: 0001425205
Report date: 2023-03-31
Filing date: 2023-05-10
Form: 10-Q
Primary document: iova-20230331x10q.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.